The Lancet in conversation with
Richard Horton on the Oxford vaccine phase 3 trial
December 08, 2020
The Lancet
Richard Horton on the Oxford vaccine phase 3 trial
The Lancet in conversation with
More Info
Share
The Lancet in conversation with
Richard Horton on the Oxford vaccine phase 3 trial
Dec 08, 2020
The Lancet
Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv